White William Richard
Related Filers (3)
Other (2)
144
Tuesday, 12/12/2023
Filing for proposed sale of securities under Rule 144
144
Tuesday, 6/20/2023
Filing for proposed sale of securities under Rule 144
Ownership (38)
4
Tuesday, 1/23/2024
Ventyx Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 12/18/2023
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 12/14/2023
Disc Medicine, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/12/2023
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 11/13/2023
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 9/25/2023
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/22/2023
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/15/2023
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/12/2023
Ventyx Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/9/2023
Disc Medicine, Inc.: Statement of changes in beneficial ownership of securities
4/A
Wednesday, 4/26/2023
Ventyx Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/14/2023
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/24/2023
Ventyx Biosciences, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 1/3/2023
Disc Medicine, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 1/3/2023
Disc Medicine, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 12/29/2022
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/20/2022
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/13/2022
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 10/17/2022
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 9/15/2022
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 9/13/2022
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/10/2022
Ventyx Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/18/2022
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 12/23/2021
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 12/20/2021
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 12/10/2021
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/3/2021
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 10/20/2021
Ventyx Biosciences, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 10/5/2021
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 9/3/2021
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/4/2021
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 7/8/2021
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/4/2021
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 4/5/2021
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/9/2020
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 1/3/2020
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 12/13/2019
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 6/19/2019
Akero Therapeutics, Inc.: Initial statement of beneficial ownership of securities